Kenvue Inc. (NYSE:KVUE) Shares Purchased by Huber Capital Management LLC

Huber Capital Management LLC raised its holdings in Kenvue Inc. (NYSE:KVUE) by 15.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 169,300 shares of the company’s stock after buying an additional 22,900 shares during the quarter. Huber Capital Management LLC’s holdings in Kenvue were worth $3,615,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Paloma Partners Management Co purchased a new stake in Kenvue in the third quarter valued at approximately $360,000. Benjamin Edwards Inc. purchased a new stake in shares of Kenvue during the 3rd quarter valued at $1,323,000. Hilltop Holdings Inc. grew its stake in shares of Kenvue by 3.1% during the 3rd quarter. Hilltop Holdings Inc. now owns 80,331 shares of the company’s stock valued at $1,858,000 after buying an additional 2,434 shares during the period. Janus Henderson Group PLC increased its holdings in shares of Kenvue by 40.6% during the 3rd quarter. Janus Henderson Group PLC now owns 219,576 shares of the company’s stock worth $5,080,000 after buying an additional 63,400 shares during the last quarter. Finally, Investment Management Corp of Ontario boosted its holdings in Kenvue by 48.9% in the third quarter. Investment Management Corp of Ontario now owns 63,627 shares of the company’s stock valued at $1,472,000 after acquiring an additional 20,900 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the company. Piper Sandler upped their price target on Kenvue from $24.00 to $27.00 and gave the stock an “overweight” rating in a research note on Monday, February 24th. Barclays increased their target price on shares of Kenvue from $21.00 to $23.00 and gave the stock an “equal weight” rating in a research report on Thursday, March 27th. UBS Group decreased their price objective on shares of Kenvue from $23.00 to $21.00 and set a “neutral” rating for the company in a research note on Friday, February 7th. Evercore ISI started coverage on shares of Kenvue in a report on Monday, March 24th. They set an “in-line” rating and a $25.00 target price on the stock. Finally, Deutsche Bank Aktiengesellschaft cut shares of Kenvue from a “buy” rating to a “hold” rating and decreased their price target for the stock from $25.00 to $24.00 in a research report on Thursday, December 12th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $24.00.

Kenvue Stock Down 0.0 %

Shares of NYSE KVUE opened at $23.87 on Thursday. The firm has a market cap of $45.62 billion, a price-to-earnings ratio of 45.04, a PEG ratio of 2.62 and a beta of 1.25. Kenvue Inc. has a 1 year low of $17.67 and a 1 year high of $24.46. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00. The stock’s 50-day simple moving average is $22.50 and its 200-day simple moving average is $22.47.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Thursday, February 6th. The company reported $0.26 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. As a group, equities analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Wednesday, February 12th were paid a dividend of $0.205 per share. The ex-dividend date was Wednesday, February 12th. This represents a $0.82 dividend on an annualized basis and a yield of 3.44%. Kenvue’s dividend payout ratio (DPR) is 154.72%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.